News

NABR Celebrates CITES Committee's Support for Macaque Research

NABR Celebrates CITES Committee's Support for Macaque Research

NABR Applauds CITES Standing Committee's Decision

The National Association for Biomedical Research (NABR) expresses strong approval of the CITES Standing Committee's recent decision regarding long-tailed macaques.

Importance of Long-Tailed Macaques in Research

This decision reflects the international community's commitment to a science-based review process, allowing ample time to investigate the pertinent information surrounding macaque trade.

International Support for Science-Based Policies

In a momentous show of solidarity, multiple countries emphasized the necessity of thorough reviews before making substantial trade decisions. NABR particularly commends the contributions from several nations aligning with Japan's deferment request.

The CITES Standing Committee Meeting

During the critical discussions in Geneva, Switzerland, representatives from various countries voiced concerns regarding claims made about Cambodia's macaque exports. The committee highlighted the need to appraise new information provided by Cambodia before any trade actions could be endorsed.

Ensuring Transparency and Scientific Integrity

NABR highlights the committee's decision as a triumph for scientific integrity, supporting an evidence-driven approach to international wildlife trade policies while safeguarding public health aspirations.

NABR’s Continued Advocacy for Biomedical Research

Matthew R. Bailey, NABR President, articulated the significance of this decision, asserting that biomedicine's reliance on long-tailed macaques is crucial for advancing research in critical areas such as infectious diseases and cancer treatment. This acknowledgment of the need for comprehensive deliberation is vital for informed actions that impact health outcomes for many.

A Commitment to Ethical Research Practices

With unwavering dedication, NABR is determined to collaborate with global stakeholders to champion policies that uphold ethical research practices. Ensuring that international wildlife trade decisions complement biomedical advancements remains a priority.

About NABR

Established in 1979, the National Association for Biomedical Research stands as a pivotal nonprofit organization committed to promoting sound public policy regarding the humane use of animals in research. Currently, NABR boasts a diverse membership that includes over 340 universities and esteemed institutions committed to upholding responsible animal research initiatives.

Contact Information

For further information, reach out to Eva Maciejewski at NABR. You can connect through direct lines or visit our official website for more details.

Frequently Asked Questions

What is the CITES Standing Committee's decision regarding long-tailed macaques?

The committee decided against imposing a trade suspension, favoring a thorough review of the facts.

Why is the availability of long-tailed macaques important for biomedical research?

Long-tailed macaques are essential for conducting vital research related to infectious diseases and cancer treatments.

How does NABR feel about CITES' decision?

NABR applauds the decision as a victory for scientific integrity and evidence-based policy-making.

What support did Japan receive during the CITES meeting?

Japan received backing from multiple countries that stressed the importance of deferring any immediate decisions on the trade suspension.

What is the mission of the National Association for Biomedical Research?

NABR advocates for the humane use of animals in research and supports policies that enhance global human and animal health.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 8

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 10

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 5

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 5

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 4

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 4

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 5

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Rise and Fall of MedMen's Cannabis Empire

Updated Category News Views 178

Let's slice through the smoke and mirrors of MedMen's saga—a story that captures the dizzying heights and staggering lows of what was once the poster child for America's cannabis gold rush. The buzz is about a documentary from Bungalow Media + Entertainment that’s gearing up to pull back the curtain on Adam Bierman and his rollercoaster ride with MedMen. They kicked...

Continue Reading
Draganfly Secures $25 Million for Innovative Drone Solutions

Updated Category News Views 136

Overview of Recent Financial Activities Draganfly Inc. (NASDAQ: DPRO), a leader in drone technology and robotics, has made significant strides in its financial landscape by securing a registered direct offering. This initiative is designed to enhance their operational capabilities and support new product developments. Details of the Direct Offering In a recent...

Continue Reading
Current Sentiment Analysis: Canaan Inc's Short Interest Insights

Updated Category News Views 304

Canaan Inc's Current Short Interest Overview Canaan Inc (NYSE: CAN) is witnessing changes in its stock sentiment, particularly regarding its short interest. Recent reports indicate that the short interest, expressed as a percentage of the float, has dropped by 8.14%. Currently, 36.17 million shares are sold short, representing 8.58% of the total shares available for...

Continue Reading
iHerb's Chief Operating Officer Miriee Chang Set to Retire

Updated Category News Views 196

iHerb Announces Retirement of COO Miriee Chang iHerb, a global leader in online retail for wellness products, has announced the planned retirement of Chief Operating Officer Miriee Chang. This change marks a significant transition for the company, dedicated to maintaining its operational excellence and customer service quality. Continuity During the Transition Miriee...

Continue Reading
Liberty Broadband to Reveal Q4 2024 Performance in Upcoming Call

Updated Category News Views 103

Liberty Broadband Corporation's Upcoming Conference Call Liberty Broadband Corporation (Nasdaq: LBRDA, LBRDK, LBRDP) is gearing up for a significant event as it prepares to hold a conference call to unveil its financial results for the fourth quarter of 2024. This highly anticipated call is set to take place soon, providing an opportunity for stakeholders and interested...

Continue Reading